Published on 30/11/2025

Sampling for ECs: Minimal Yet Defensible

Introduction to Change Control in Pharmaceuticals

The pharmaceutical industry operates under strict regulatory requirements to ensure product safety and efficacy. A crucial element of this process is change control, which manages changes in processes, equipment, and materials. This tutorial will outline the principles and practices for effectively conducting change control impact assessments, particularly focusing on the need for sampling as part of effectiveness checks and periodic reviews in line with regulatory expectations from the FDA, EMA, and MHRA.

Change control processes typically require a systematic approach, integrating risk-based change thresholds to determine if a change necessitates further validation work—such as verification vs re-validation. This article will guide you through establishing a robust sampling plan that meets these requirements.

Understanding Change Control Impact Assessment

A change control impact assessment identifies potential impacts of a proposed change on product quality, safety, and compliance. It invariably forms a part of the quality management system (QMS) aspects defined by regulations, such as 21 CFR Part 211. The impact assessment should include:

• Nature of Change: Aspects of the process, such as material attributes, equipment modifications, or production techniques.
• Risk Analysis: Evaluating potential risks associated with the change in line with risk management principles.
• Documentation Requirements: Ensuring all aspects of change control are documented and traceable within the QMS.

Implementing a thorough change control impact assessment ensures that changes undergo adequate scrutiny while providing a defensible rationale for decisions made. This process will also ultimately assist in sampling plan updates that need to reflect the adjustments and any new risks identified.

Verification vs. Re-Validation: Key Differences and Implications

Within change control assessments, the terms verification and re-validation play a significant role in determining what actions are needed post-change.

Verification

Verification is typically a smaller-scale check designed to ensure that a change has been implemented correctly. It can involve simple checks such as documentation reviews or physical inspections, confirming that the changed process or system meets predefined requirements without the need for extensive validation studies.

Re-Validation

In contrast, re-validation is required when a significant change is made that affects product quality, safety, or compliance. This often entails conducting new validation studies and obtaining additional data to demonstrate that the product continues to meet all requirements.

Dependencies on the nature of the change and a thorough understanding of regulatory expectations must guide decisions on whether to execute verification or re-validation. Utilizing risk-based change thresholds will aid in determining the required level of validation activity against the specific change being assessed.

Implementing a Risk-Based Approach to Change Control

Establishing a risk-based approach entails adopting strategies that mitigate risks associated with changes effectively. This can involve:

• Risk Assessment Matrix: Creating a matrix that identifies potential risks and their consequences, ensuring that higher-risk changes receive more thorough scrutiny.
• Engaging Stakeholders: Involving cross-functional teams in risk evaluation can provide diverse perspective and expertise.
• Regular Review: Periodic review of the risk management strategy ensures it remains relevant, incorporating lessons learned from previous change control experiences.

By using a risk-based framework, companies can prioritize resources efficiently, identifying which changes necessitate detailed sampling plans and the extent to which those plans should be adjusted based on identified risk factors.

Designing Effective Sampling Plans

Effective sampling plans are critical to demonstrate that processes remain in control following a change. Sampling plans should be derived from various factors, including risk assessments and historical data. Implementing a sound sampling strategy involves the following steps:

Step 1: Define Objectives

The first step in designing a sampling plan is identifying its purpose. Objectives can include:

• Confirming the consistency and quality of products after a change.
• Ensuring compliance with regulatory standards.
• Providing data and evidence packs to support change control submissions.

Step 2: Determine Sample Size

Sample size determination is either statistical or judgmental based on the risk profile of the change. A larger sample size may be warranted for changes with higher risk, leading to more reliable data collection and analysis.

Step 3: Sampling Methodology

Choose a methodology that reflects the objectives of testing. Common sampling methods include:

• Random Sampling: Selected randomly from a batch to ensure unbiased results.
• Systematic Sampling: Selecting samples at regular intervals throughout a batch.
• Stratified Sampling: Dividing the population into subgroups and sampling from each significant category.

Step 4: Establish Critical Process Variables (CPV)

Defining Critical Process Variables (CPV) will allow you to set limits and specifications for sampling. CPV limits can then be easily adjusted based on observed trends and compliance with both internal and regulatory standards.

Integration of Bridging Studies in Change Control

Bridging studies play a vital role when implementing changes, particularly in transferring validation for a given method or process from one condition to another. They allow for differences in design between the accreditation of a product in one process environment versus another. When changes in scale, technology, or process changes are made, conducting bridging studies confirms that the essential quality attributes are maintained across different conditions.

To develop effective bridging studies:

• Identify changes that necessitate validation.
• Clearly define quality attributes and acceptance criteria.
• Involve key stakeholders in the study design for comprehensive knowledge integration.

Conducting bridging studies ensures continuous compliance and provides critical evidence packs that can be reviewed during regulatory submissions, supporting the change control impact assessment process.

Continuous Effectiveness Checks and Periodic Review

To maintain compliance and robust product quality, continuous effectiveness checks and periodic reviews are integral components of the change control strategy. Establishing a framework for these checks involves:

• Schedule Reviews: Systematic review intervals should be established to evaluate processes post-change.
• Data Collection: Regularly collect data from processes to facilitate evidence packs and demonstrate ongoing consistency.

Documentation and Evidence Packs

Before any periodic review, ensure that all changes to processes and systems are well documented. Evidence packs generated should include:

• Detailed records of changes made.
• Sampling results.
• Any investigations or corrective actions taken post-implementation.

These records should be easily accessible and aligned with both internal and external audit requirements, demonstrating the integrity of the change control process.

Conclusion

Pharmaceutical companies are mandated to demonstrate that their change control processes are effective, compliant, and defensible against scrutiny. In summary, taking a systematic approach to change control impact assessment by implementing effective sampling plans, utilizing bridging studies, and conducting continuous effectiveness checks are fundamental practices to ensure compliance with regulatory standards. Organizations must ensure they reference their practices against guidelines set forth in EU’s Annex 15 and established criteria from organizations like the FDA and EMA. By doing this, they not only maintain product quality but also foster a culture of continuous improvement within their operations.

Regular training and updates for staff involved in these processes further ensure understanding and compliance over time. By following these outlined steps, pharmaceutical professionals can lead their organizations to uphold regulatory standards while confidently adapting to changes in processes, technology, and market demands.